Your browser doesn't support javascript.
loading
Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America.
Carpp, Lindsay N; Fong, Youyi; Bonaparte, Matthew; Moodie, Zoe; Juraska, Michal; Huang, Ying; Price, Brenda; Zhuang, Yingying; Shao, Jason; Zheng, Lingyi; Chambonneau, Laurent; Small, Robert; Sridhar, Saranya; DiazGranados, Carlos A; Gilbert, Peter B.
Afiliação
  • Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Bonaparte M; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
  • Moodie Z; Global Clinical Immunology, Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America.
  • Juraska M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Price B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Zhuang Y; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
  • Shao J; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
  • Zheng L; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
  • Chambonneau L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Small R; Global Clinical Immunology, Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America.
  • Sridhar S; Clinical Sciences, Sanofi Pasteur, Marcy-L'Etoile, France.
  • DiazGranados CA; Sanofi Pasteur, Orlando, Florida, United States of America.
  • Gilbert PB; Clinical Sciences, Sanofi Pasteur, Marcy-L'Etoile, France.
PLoS One ; 15(6): e0234236, 2020.
Article em En | MEDLINE | ID: mdl-32542024

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes de Neutralização / Vacinas contra Dengue Tipo de estudo: Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes de Neutralização / Vacinas contra Dengue Tipo de estudo: Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article